|
|
Volumn , Issue , 2009, Pages 267-272
|
|
Antiplatelet agents.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ACETYLSALICYLIC ACID;
ANTITHROMBOCYTIC AGENT;
CLOPIDOGREL;
DRUG DERIVATIVE;
FIBRINOGEN RECEPTOR;
PURINERGIC P2 RECEPTOR;
PURINERGIC P2Y12 RECEPTOR;
TICLOPIDINE;
CARDIOVASCULAR DISEASE;
CLASSIFICATION;
CLINICAL TRIAL;
DOSE RESPONSE;
DRUG ANTAGONISM;
DRUG COMBINATION;
DRUG DELIVERY SYSTEM;
DRUG EFFECT;
DRUG RESISTANCE;
FORECASTING;
HUMAN;
PRACTICE GUIDELINE;
REVIEW;
THROMBOCYTE ACTIVATION;
ASPIRIN;
CARDIOVASCULAR DISEASES;
CLINICAL TRIALS AS TOPIC;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG DELIVERY SYSTEMS;
DRUG RESISTANCE;
DRUG THERAPY, COMBINATION;
FORECASTING;
HUMANS;
PLATELET ACTIVATION;
PLATELET AGGREGATION INHIBITORS;
PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX;
PRACTICE GUIDELINES AS TOPIC;
RECEPTORS, PURINERGIC P2;
TICLOPIDINE;
|
|
EID: 77949484233
PISSN: None
EISSN: 15204383
Source Type: Journal
DOI: 10.1182/asheducation-2009.1.267 Document Type: Review |
|
Times cited : (31)
|
|
References (52)
|
